FOSL2 promotes VEGF-independent angiogenesis by transcriptionnally activating Wnt5a in breast cancer-associated fibroblasts
Xueying Wan, Shengdong Guan, Yixuan Hou, Yilu Qin, Huan Zeng, Liping Yang, Yina Qiao, Shuiqing Liu, Qiao Li, Ting Jin, Yuxiang Qiu, Manran Liu
Abstract
FOSL2/Wnt5a signaling plays an essential role in breast cancer angiogenesis in a VEGF-independent manner, and targeting the FOSL2/Wnt5a signaling axis in CAFs may offer a potential option for antiangiogenesis therapy.
Topics & Concepts
AngiogenesisStromal cellCancer researchBiologyVascular endothelial growth factorVascular endothelial growth factor ASprouting angiogenesisNeovascularizationPathologyMedicineVEGF receptorsAngiogenesis and VEGF in CancerGalectins and Cancer BiologyWnt/β-catenin signaling in development and cancer